Advertisement
Screener

Harrow, Inc. (HROW) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

HARROW, INC. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • HARROW, INC. return tang equity for the quarter ending 2026-06-30 was 23.21%, a 188.36% increase year-over-year.
  • HARROW, INC. return tang equity for the quarter ending 2026-03-31 was 9.82%, a 43.70% decline year-over-year.
  • HARROW, INC. return tang equity for the quarter ending 2025-12-31 was 4.19%, a 72.36% decline year-over-year.
  • HARROW, INC. return tang equity for the quarter ending 2025-09-30 was 3.98%, a 84.36% decline year-over-year.
  • HARROW, INC. return tang equity for fiscal 2025 was 4.19%, a 72.36% decline from fiscal 2024.
  • HARROW, INC. return tang equity for fiscal 2024 was 15.15%, a 44.60% decline from fiscal 2023.
  • HARROW, INC. return tang equity for fiscal 2023 was 27.34%, a 45384.53% increase from fiscal 2022.
  • HARROW, INC. return tang equity for fiscal 2022 was 0.06%, a 99.98% decline from fiscal 2021.
Available history
1999-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-3023.21%-$37.23M-$160.36M
2026-03-319.82%-$14.96M-$152.35M
2025-12-314.19%-$5.14M-$122.73M
2025-09-303.98%-$4.99M-$125.46M
2025-06-308.05%-$10.23M-$127.05M
2025-03-3117.44%-$21.7M-$124.39M
2024-12-3115.15%-$17.48M-$115.4M
2024-09-3025.42%-$33.41M-$131.4M
2024-06-3034.81%-$33.58M-$96.45M
2024-03-3132.33%-$31.33M-$96.92M
2023-12-3127.34%-$24.41M-$89.27M
2023-09-3016.33%-$14.21M-$87.01M
2023-06-3012.74%-$16.28M-$127.81M
2023-03-3114.05%-$18.29M-$130.17M
2022-12-310.06%-$14.09M-$23.43B
2022-09-30122.05%-$22.56M-$18.48M
2022-06-30261.52%-$24.42M-$9.34M
2022-03-31382.91%-$20.66M-$5.4M
2021-12-31391.54%-$18.01M-$4.6M
2021-09-30-64.11%-$9.44M$14.72M
2021-06-3035.26%$7.53M$21.35M
2021-03-3137.08%$9.77M$26.34M
2020-12-31-13.29%-$3.36M$25.27M
2020-09-30-7.92%-$1.85M$23.34M
2020-06-30-159.29%-$21.96M$13.78M
2020-03-31-185.30%-$24.1M$13M
2019-12-310.67%$168,000.00$25.04M
2019-09-3073.32%$15.64M$21.33M
2019-06-3082.86%$24.6M$29.68M
2019-03-3192.99%$29.5M$31.72M
2018-12-3175.13%$14.63M$19.47M
2018-09-30850.41%-$6.28M-$738,000.00
2018-06-30675.77%-$9.45M-$1.4M
2018-03-31209.00%-$10.49M-$5.02M
2017-12-31484.83%-$11.99M-$2.47M
2017-09-301122.05%-$15.32M-$1.37M
2017-06-30-542.21%-$13.47M$2.49M
2017-03-31-13800.70%-$19.6M$142,000.00
2016-12-31-1548.01%-$19.09M$1.23M
2016-09-30758.02%-$18.11M-$2.39M
2016-06-30-33110.91%-$18.21M$55,000.00
2016-03-31-537.66%-$17.3M$3.22M
2015-12-31227.58%-$15.9M-$6.99M
2015-09-30576.55%-$13.52M-$2.35M
2015-06-30-1206.83%-$12.02M$996,000.00
2015-03-31-567.57%-$10.89M$1.92M
2014-12-31-140.39%-$10.12M$7.21M
2014-09-30-99.26%-$9.26M$9.32M
2014-06-30-80.22%-$8.88M$11.07M
2014-03-31-61.63%-$8.5M$13.8M
2013-12-31-50.58%-$7.64M$15.11M
2013-09-30-44.14%-$7.21M$16.34M
2013-06-30-36.96%-$6.38M$17.27M
2013-03-31-29.73%-$5.47M$18.4M
2012-12-31-53.85%-$5.38M$10M
2012-09-30-38.93%-$4.2M$10.79M
2012-06-30-41.08%-$3.04M$7.4M
2012-03-31269.29%-$1.9M-$705,812.00
2011-12-3156.11%-$953,936.00-$1.7M
2011-09-3070.54%-$1.11M-$1.57M
2011-06-30116.21%-$1.77M-$1.52M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-314.19%-$5.14M-$122.73M
2024-12-3115.15%-$17.48M-$115.4M
2023-12-3127.34%-$24.41M-$89.27M
2022-12-310.06%-$14.09M-$23.43B
2021-12-31391.54%-$18.01M-$4.6M
2020-12-31-13.29%-$3.36M$25.27M
2019-12-310.67%$168,000.00$25.04M
2018-12-3175.13%$14.63M$19.47M
2017-12-31484.83%-$11.99M-$2.47M
2016-12-31-1548.01%-$19.09M$1.23M
2015-12-31227.58%-$15.9M-$6.99M
2014-12-31-140.39%-$10.12M$7.21M
2013-12-31-50.58%-$7.64M$15.11M
2012-12-31-53.85%-$5.38M$10M
2011-12-3156.11%-$953,936.00-$1.7M
2010-12-31243.80%-$2.53M-$1.04M
2009-12-31-788.90%-$4.55M$577,211.00
2008-12-31-72.28%-$3.3M$4.57M
2007-12-31-122.75%-$4.28M$3.49M
2006-12-31143.90%-$584,232.00-$406,005.00
2005-12-31197.83%-$539,622.00-$272,773.00
2004-12-31311.51%-$508,226.00-$163,151.00
2003-12-31377.23%-$207,196.00-$54,925.00
2002-12-31478.15%-$228,217.00-$47,729.00
2001-12-311068.16%-$208,420.00-$19,512.00
2000-12-311921.13%-$213,092.00-$11,092.00
1999-12-315100.00%-$204,000.00-$4,000.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Kardigan, Inc. (KARD)United States$1.346B